Arteriosclerosis and Thrombosis, Vol 13, 886-891, Copyright © 1993 by American Heart Association

ARTICLES

Genetic variation at the beta-fibrinogen locus in relation to plasma fibrinogen concentrations and risk of myocardial infarction. The ECTIM Study

PY Scarabin, L Bara, S Ricard, O Poirier, JP Cambou, D Arveiler, G Luc, AE Evans, MM Samama and F Cambien
INSERM, Cardiovascular Epidemiology Unit U258, Paris, France.

Increased plasma fibrinogen concentration is a major cardiovascular risk factor. Conflicting results on genetic variations in plasma fibrinogen levels have been reported. Furthermore, whether fibrinogen genotype is associated with the risk of ischemic heart disease has not been studied so far. An HaeIII restriction fragment length polymorphism of the beta-fibrinogen gene was used in a case-control study to investigate the genetic variation at this locus in relation to plasma fibrinogen concentrations and the risk of myocardial infarction (MI). Five hundred thirty-three male patients aged 27-66 years and 648 control subjects were recruited from four World Health Organization MONICA centers in Northern Ireland and in France. The absence of the HaeIII cutting site (H2 allele) was associated with a significant rise in fibrinogen concentrations in both patients and control subjects. The effect of the HaeIII polymorphism on plasma fibrinogen levels did not significantly differ between centers. Fibrinogen levels were higher in smokers than in nonsmokers. The difference between the two groups was larger in subjects with the genotype H2H2 than in those with either genotype H1H1 or H1H2, regardless of the case-control status. However, there was no significant interaction between smoking status and genotype in their effects on variance in fibrinogen levels, whereas fibrinogen levels. HaeIII genotype accounted for approximately 1% of the total variance in fibrinogen levels, whereas smoking and age together explained 7% and 5% in control subjects and patients, respectively. The frequency of the H2 allele was 0.21 in control subjects and 0.19 in patients.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				J. S. Danik, G. Pare, D. I. Chasman, R. Y.L. Zee, D. J. Kwiatkowski, A. Parker, J. P. Miletich, and P. M Ridker Novel Loci, Including Those Related to Crohn Disease, Psoriasis, and Inflammation, Identified in a Genome-Wide Association Study of Fibrinogen in 17 686 Women: The Women's Genome Health Study Circ Cardiovasc Genet, April 1, 2009; 2(2): 134 - 141. [Abstract] [Full Text] [PDF]

				W. Koch, P. Hoppmann, J. Biele, J. C. Mueller, A. Schomig, and A. Kastrati Fibrinogen Genes and Myocardial Infarction: A Haplotype Analysis Arterioscler Thromb Vasc Biol, April 1, 2008; 28(4): 758 - 763. [Abstract] [Full Text] [PDF]

				M. Verschuur, M. de Jong, L. Felida, M. P. M. de Maat, and H. L. Vos A Hepatocyte Nuclear Factor-3 Site in the Fibrinogen {beta} Promoter Is Important for Interleukin 6-induced Expression, and Its Activity Is Influenced by the Adjacent -148C/T Polymorphism J. Biol. Chem., April 29, 2005; 280(17): 16763 - 16771. [Abstract] [Full Text] [PDF]

				W. H Reinhart Fibrinogen - marker or mediator of vascular disease? Vascular Medicine, August 1, 2003; 8(3): 211 - 216. [Abstract] [PDF]

				R. L. Klein, S. J. Hunter, A. J. Jenkins, D. Zheng, A. J. Semler, J. Clore, W. T. Garvey, and The DCCT/EDIC Study Group Fibrinogen Is a Marker for Nephropathy and Peripheral Vascular Disease in Type 1 Diabetes: Studies of plasma fibrinogen and fibrinogen gene polymorphism in the DCCT/EDIC cohort Diabetes Care, May 1, 2003; 26(5): 1439 - 1448. [Abstract] [Full Text] [PDF]

				M. Martiskainen, T. Pohjasvaara, J. Mikkelsson, R. Mantyla, T. Kunnas, P. Laippala, E. Ilveskoski, M. Kaste, P.J. Karhunen, and T. Erkinjuntti Fibrinogen Gene Promoter -455 A Allele as a Risk Factor for Lacunar Stroke Stroke, April 1, 2003; 34(4): 886 - 891. [Abstract] [Full Text] [PDF]

				S. M. Boekholdt, N. R. Bijsterveld, A. H.M. Moons, M. Levi, H. R. Buller, and R. J.G. Peters Genetic Variation in Coagulation and Fibrinolytic Proteins and Their Relation With Acute Myocardial Infarction: A Systematic Review Circulation, December 18, 2001; 104(25): 3063 - 3068. [Abstract] [Full Text] [PDF]

				G.J. Blake, C. Schmitz, K. Lindpaintner, and P.M. Ridker Mutation in the promoter region of the {beta}-fibrinogen gene and the risk of future myocardial infarction, stroke and venous thrombosis Eur. Heart J., December 2, 2001; 22(24): 2262 - 2266. [Abstract] [PDF]

				R Marchioli, F Avanzini, F Barzi, C Chieffo, A Di Castelnuovo, M.G Franzosi, E Geraci, A.P Maggioni, R.M Marfisi, N Mininni, et al. Assessment of absolute risk of death after myocardial infarction by use of multiple-risk-factor assessment equations; GISSI-Prevenzione mortality risk chart Eur. Heart J., November 2, 2001; 22(22): 2085 - 2103. [Abstract] [PDF]

				W.-H. Lee, T.-H. Hwang, G. T. Oh, S. U. Kwon, Y.-H. Choi, and J.-E. Park Genetic factors associated with endothelial dysfunction affect the early onset of coronary artery disease in Korean males Vascular Medicine, May 1, 2001; 6(2): 103 - 108. [Abstract] [PDF]

				M. S. Williams and P. F. Bray Genetics of Arterial Prothrombotic Risk States Experimental Biology and Medicine, May 1, 2001; 226(5): 409 - 419. [Abstract] [Full Text]

				A. Woods, D.J. Brull, S.E. Humphries, and H.E. Montgomery Genetics of inflammation and risk of coronary artery disease: the central role of interleukin-6 Eur. Heart J., October 1, 2000; 21(19): 1574 - 1583. [PDF]

				F. M. van ’t Hooft, S. J. F. von Bahr, A. Silveira, A. Iliadou, P. Eriksson, and A. Hamsten Two Common, Functional Polymorphisms in the Promoter Region of the {beta}-Fibrinogen Gene Contribute to Regulation of Plasma Fibrinogen Concentration Arterioscler Thromb Vasc Biol, December 1, 1999; 19(12): 3063 - 3070. [Abstract] [Full Text] [PDF]

				R. P. Tracy, A. M. Arnold, W. Ettinger, L. Fried, E. Meilahn, and P. Savage The Relationship of Fibrinogen and Factors VII and VIII to Incident Cardiovascular Disease and Death in the Elderly : Results From the Cardiovascular Health Study Arterioscler Thromb Vasc Biol, July 1, 1999; 19(7): 1776 - 1783. [Abstract] [Full Text] [PDF]

				G. Maresca, A. Di Blasio, R. Marchioli, and G. Di Minno Measuring Plasma Fibrinogen to Predict Stroke and Myocardial Infarction : An Update Arterioscler Thromb Vasc Biol, June 1, 1999; 19(6): 1368 - 1377. [Abstract] [Full Text] [PDF]

				R. Anwar, L. Gallivan, S. D. Edmonds, and A. F. Markham Genotype/Phenotype Correlations for Coagulation Factor XIII: Specific Normal Polymorphisms Are Associated With High or Low Factor XIII Specific Activity Blood, February 1, 1999; 93(3): 897 - 905. [Abstract] [Full Text] [PDF]

				E. T. Brown and G. M. Fuller Detection of a Complex That Associates With the Bbeta Fibrinogen G-455-A Polymorphism Blood, November 1, 1998; 92(9): 3286 - 3293. [Abstract] [Full Text] [PDF]

				J. S. Pankow, A. R. Folsom, M. A. Province, D. C. Rao, R. R. Williams, J. Eckfeldt, and T. A. Sellers Segregation Analysis of Plasminogen Activator Inhibitor-1 and Fibrinogen Levels in the NHLBI Family Heart Study Arterioscler Thromb Vasc Biol, October 1, 1998; 18(10): 1559 - 1567. [Abstract] [Full Text] [PDF]

				S. M. Grundy, G. J. Balady, M. H. Criqui, G. Fletcher, P. Greenland, L. F. Hiratzka, N. Houston-Miller, P. Kris-Etherton, H. M. Krumholz, J. LaRosa, et al. Primary Prevention of Coronary Heart Disease: Guidance From Framingham : A Statement for Healthcare Professionals From the AHA Task Force on Risk Reduction Circulation, May 19, 1998; 97(18): 1876 - 1887. [Full Text] [PDF]

				J. G. van der Bom, M. P. M. de Maat, M. L. Bots, F. Haverkate, P. T. V. M. de Jong, A. Hofman, C. Kluft, and D. E. Grobbee Elevated Plasma Fibrinogen : Cause or Consequence of Cardiovascular Disease? Arterioscler Thromb Vasc Biol, April 1, 1998; 18(4): 621 - 625. [Abstract] [Full Text] [PDF]

				H. Schmidt, R. Schmidt, K. Niederkorn, S. Horner, P. Becsagh, B. Reinhart, M. Schumacher, V. Weinrauch, and G. M. Kostner ß-Fibrinogen Gene Polymorphism (C148->T) Is Associated With Carotid Atherosclerosis : Results of the Austrian Stroke Prevention Study Arterioscler Thromb Vasc Biol, March 1, 1998; 18(3): 487 - 492. [Abstract] [Full Text] [PDF]

				M. P. M. de Maat, J. J. P. Kastelein, J. W. Jukema, A. H. Zwinderman, H. Jansen, B. Groenemeier, A. V. G. Bruschke, and C. Kluft -455G/A Polymorphism of the ß-Fibrinogen Gene is Associated With the Progression of Coronary Atherosclerosis in Symptomatic Men : Proposed Role for an Acute-Phase Reaction Pattern of Fibrinogen Arterioscler Thromb Vasc Biol, February 1, 1998; 18(2): 265 - 271. [Abstract] [Full Text] [PDF]

				A. R Pries, T. W Secomb, M. Sperandio, and P. Gaehtgens Blood flow resistance during hemodilution: effect of plasma composition Cardiovasc Res, January 1, 1998; 37(1): 225 - 235. [Abstract] [Full Text] [PDF]

				F. Zito, A. Di Castelnuovo, C. Amore, A. D'Orazio, M. B. Donati, and L. Iacoviello Bcl I Polymorphism in the Fibrinogen ß-Chain Gene Is Associated With the Risk of Familial Myocardial Infarction by Increasing Plasma Fibrinogen Levels : A Case-Control Study in a Sample of GISSI-2 Patients Arterioscler Thromb Vasc Biol, December 1, 1997; 17(12): 3489 - 3494. [Abstract] [Full Text]

				P. Clarkson, D. S. Celermajer, A. J. Powe, A. E. Donald, R. M. A. Henry, and J. E. Deanfield Endothelium-Dependent Dilatation Is Impaired in Young Healthy Subjects With a Family History of Premature Coronary Disease Circulation, November 18, 1997; 96(10): 3378 - 3383. [Abstract] [Full Text]

				C. Kessler, C. Spitzer, D. Stauske, S. Mende, J. Stadlmuller, R. Walther, and R. Rettig The Apolipoprotein E and ß-Fibrinogen G/A-455 Gene Polymorphisms Are Associated With Ischemic Stroke Involving Large-Vessel Disease Arterioscler Thromb Vasc Biol, November 1, 1997; 17(11): 2880 - 2884. [Abstract] [Full Text]

				N. J. Samani and D. Lodwick Glycoprotein IIIa polymorphism and risk of myocardial infarction Cardiovasc Res, March 1, 1997; 33(3): 693 - 697. [Abstract] [PDF]

				X.L. Wang, J. Wang, R.M. McCredie, and D.E.L. Wilcken Polymorphisms of Factor V, Factor VII, and Fibrinogen Genes: Relevance to Severity of Coronary Artery Disease Arterioscler Thromb Vasc Biol, February 1, 1997; 17(2): 246 - 251. [Abstract] [Full Text]

				F. Cambien, S. Ricard, A. Troesch, C. Mallet, L. Generenaz, A. Evans, D. Arveiler, G. Luc, J.-B. Ruidavets, and O. Poirier Polymorphisms of the Transforming Growth Factor-ß1 Gene in Relation to Myocardial Infarction and Blood Pressure: The Etude Cas-Temoin de l'Infarctus du Myocarde (ECTIM) Study Hypertension, November 1, 1996; 28(5): 881 - 887. [Abstract] [Full Text]

				H. E. Montgomery, P. Clarkson, O.M. Nwose, D.P. Mikailidis, I.A. Jagroop, C. Dollery, J. Moult, F. Benhizia, J. Deanfield, M. Jubb, et al. The Acute Rise in Plasma Fibrinogen Concentration With Exercise Is Influenced by the G-453-A Polymorphism of the ß-Fibrinogen Gene Arterioscler Thromb Vasc Biol, March 1, 1996; 16(3): 386 - 391. [Abstract] [Full Text]

				I. Behague, O. Poirier, V. Nicaud, A. Evans, D. Arveiler, G. Luc, J.-P. Cambou, P.-Y. Scarabin, L. Bara, F. Green, et al. ß Fibrinogen Gene Polymorphisms Are Associated With Plasma Fibrinogen and Coronary Artery Disease in Patients With Myocardial Infarction : The ECTIM Study Circulation, February 1, 1996; 93(3): 440 - 449. [Abstract] [Full Text]

				M. P.M. de Maat, P. de Knijff, F. R. Green, A. E. Thomas, J. Jespersen, and C. Kluft Gender-Related Association Between ß-Fibrinogen Genotype and Plasma Fibrinogen Levels and Linkage Disequilibrium at the Fibrinogen Locus in Greenland Inuit Arterioscler Thromb Vasc Biol, July 1, 1995; 15(7): 856 - 860. [Abstract] [Full Text]

				S. E. Humphries, S. Ye, P. Talmud, L. Bara, L. Wilhelmsen, and L. Tiret European Atherosclerosis Research Study: Genotype at the Fibrinogen Locus (G-455-A ß-Gene) Is Associated With Differences in Plasma Fibrinogen Levels in Young Men and Women From Different Regions in Europe : Evidence for Gender-Genotype-Environment Interaction Arterioscler Thromb Vasc Biol, January 1, 1995; 15(1): 96 - 104. [Abstract] [Full Text]